Vericel (VCEL) Operating Expenses (2010 - 2026)
Vericel (VCEL) reported Operating Expenses of $57.3 million for Q1 2026, up 16.85% on a YoY basis from $49.1 million in Q1 2025, and up 13.05% sequentially from $50.7 million in Q4 2025.
Vericel (VCEL) Operating Expenses (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Operating Expenses data on file, last reported at $57.3 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses rose 16.85% year-over-year to $57.3 million; the trailing twelve-month figure through Mar 2026 stood at $202.8 million (up 15.35% YoY), and the FY2025 full-year result was $194.6 million, up 16.09% from the prior year.
- Operating Expenses rose to $57.3 million in Q1 2026, from $50.7 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $57.3 million in Q1 2026 to a low of $30.7 million in Q1 2022.
- A 5-year average of $40.5 million and a median of $40.0 million in 2024 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses gained 4.23% in 2022 and rose 26.72% in 2025, its largest moves.
- Tracing VCEL's Operating Expenses over 5 years: stood at $32.2 million in 2022, then rose by 11.23% to $35.8 million in 2023, then grew by 11.86% to $40.0 million in 2024, then increased by 26.72% to $50.7 million in 2025, then rose by 13.05% to $57.3 million in 2026.
- Business Quant data shows VCEL's Operating Expenses at $57.3 million in Q1 2026, $50.7 million in Q4 2025, and $46.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 57.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.33 Mn |
| Dec 31, 2025 | 50.71 Mn |
| Sep 30, 2025 | 46.14 Mn |
| Jun 30, 2025 | 48.64 Mn |
| Mar 31, 2025 | 49.07 Mn |
| Dec 31, 2024 | 40.02 Mn |
| Sep 30, 2024 | 44.12 Mn |
| Jun 30, 2024 | 42.63 Mn |
| Mar 31, 2024 | 40.82 Mn |
| Dec 31, 2023 | 35.78 Mn |
| Sep 30, 2023 | 35.67 Mn |
| Jun 30, 2023 | 35.90 Mn |
| Mar 31, 2023 | 34.70 Mn |
| Dec 31, 2022 | 32.16 Mn |
| Sep 30, 2022 | 32.02 Mn |
| Jun 30, 2022 | 31.94 Mn |
| Mar 31, 2022 | 30.73 Mn |
| Dec 31, 2021 | 29.89 Mn |
| Sep 30, 2021 | 27.06 Mn |
| Jun 30, 2021 | 30.64 Mn |